Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal versus intramuscular influenza vaccination in immunocompromised adults
NL-OMON26830Active, not recruiting
- Sponsor
- N/A
- Start
- Oct 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of influenza vaccine in influenza (2 arms), sponsored by N/A. Primary endpoint: Geometric mean titer at 30 days post vaccination. Started Oct 2005; status: active, not recruiting.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON26830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26830.